Homepage Greenfield MC newsroom

Greenfield MC announces Joint Venture with Canadian licensed producer EPHS Holdings Inc to cultivate medicinal cannabis in Australia

Announcement posted by Greenfield MC 06 Aug 2019

The JV will see Greenfield MC add cultivation of medicinal cannabis to its existing import and distribution activities
Media Release

Greenfield MC announces Joint Venture with Canadian licensed producer EPHS Holdings Inc. to cultivate medicinal cannabis in Australia
  •  The Joint Venture will see Greenfield MC add cultivation of medicinal cannabis to its existing import and distribution activities
  • Greenfield MC will launch a Series B investment round in late Q3 2019
Greenfield MC, a rising player in the Australian medicinal cannabis market and EPHS Holdings Inc. (STNN:US), a US-listed commercial cannabis producer with grow operations in Canada, have announced a joint venture to cultivate medicinal cannabis in Australia. The joint venture will be oriented towards exporting to Asia, which is expected to become the world’s largest patient and consumer market for medicinal cannabis.
The joint venture will combine Greenfield MC’s local and international medical and pharmaceutical expertise with EPHS’s many years of experience and proven track record in commercial cannabis cultivation.
EPHS has been growing medical-grade cannabis for several years and has been approved as a Health Canada Licensed Producer since 2013.
“EPHS has the kind of in-depth knowledge and track record that will assist us to quickly establish ourselves as leading cultivators here in Australia,” says Greenfield MC CEO Nicholas Hanna. “They have expertise in establishing state-of-the-art cultivation facilities, IP and genetics, and numerous strategic global partnerships. That leverage will allow Greenfield MC to hit the ground running when it comes to Australian cultivation. With EPHS at the helm, there will be no need to re-invent the wheel or learn on the job, and we can avoid teething and execution issues.”
“This joint venture with Greenfield MC has come at just the right time for us,” explains Stevan Perry, President of EPHS. “EPHS is a leader in the North American cultivation space. Our plan is to take our years of commercial experience, expertise and know-how into the global marketplace to cater to what promises to be a wave of industry development across Australia and the Asia-Pacific, capitalising on projected consumer numbers growth, and increasing regulatory awareness of the healthcare benefits of this new pharmaceutical product category. We have been looking for a medicinal cannabis company in Australia to partner with that shares our vision of providing high-quality low-cost medicinal cannabis, and we’re excited to have found it in Greenfield MC. Through our joint venture, we are perfectly positioned to open up these new markets.”
Cultivation under the joint venture is expected to commence in late-2020. Locations are currently being scouted for establishment of the cultivation facility, with Queensland’s Sunshine Coast of particular interest due to its favourable climate and natural light-cycle.
Continues Hanna, “We are very proud to partner with such a well-respected organisation in the global cannabis space and believe this partnership will bring to market Australian-grown medicinal cannabis products for hundreds of thousands of Australian patients with a wide range of health conditions.”
“Australia’s reputation for best agricultural practices, crop safety management systems and robust quality control will make Australian-grown cannabis the envy of the global market and provide patients with confidence in this new form of medical treatment”, explains Kevin Smith, EPHS’s Vice President for Strategy and Business Development. “For those very reasons, we see Australia as the gateway to Asia, which it already is in various agricultural and pharmaceutical product categories.”
Members of the EPHS team will relocate to Australia to assist with the establishment and operation of the local cultivation facility. The EPHS team will look to replicate its proven high yield low cost energy production methods to deliver premium quality medicinal cannabis to Asia-Pacific markets.
“It’s extremely important to us at EPHS to integrate ourselves into each community that we operate in,” adds Perry. “Our joint venture with Greenfield MC will see us share our many years of experience in cultivation with the team on the ground in Australia, helping them to avoid the many traps and pitfalls that new cultivators can often face. We hope to be Australia’s and the Asia-Pacific’s trusted supplier of medicinal cannabis crops and products.”
The joint venture marks a key milestone in Greenfield MC’s plan to become a leading producer and supplier of medicinal cannabis products in the Asia-Pacific and Oceania regions.
Greenfield MC will launch a Series B investment round in late Q3 2019.

Distributed by Uproar Marketing on behalf of Greenfield MC.
Media contact: Rachel McDougall | 0401 694 301 | rachel@uproarmarketing.com.au

See Previous Announcement: Australian Medicinal Cannabis Startup Secures Leading Oncologist as CMO

About Greenfield MC

Greenfield MC is a licenced medicinal cannabis importer and distributor in Australia, with expanding operations in cultivation, research and distribution in the Asia-Pacific region.
Independent and privately owned, Greenfield MC focuses on medicine, science and results.

Formed in 2018, Greenfield MC has a vision to be Asia-Pacific’s leading wholesaler and patient-retailer of medicinal cannabis products. Headquartered in Sydney, Australia, Greenfield MC is also represented across Melbourne and Brisbane in Australia, as well as New Zealand, South Korea and the Philippines.

For further information visit www.greenfieldmc.com.au
About EPHS Holdings Inc. (STNN:US)

EPHS Holdings Inc. is a licensed commercial cannabis cultivator engaging in the cultivation, possession, research, processing, sales, and distribution of medicinal and recreational cannabis under the licensing regime of a Health Canada Licensed Producer.
EPHS has an existing grow operation in Montreal and is constructing a second grow operation in Merritt BC, which should scale up to 1.2 million square feet (28 acres) of cultivating greenhouses.
EPHS is committed to delivering premium medical cannabis using fully integrated purpose built, intelligently controlled buildings coupled with environmentally friendly low-cost energy and micro grid systems.
For further information visit www.ephsholdings.com